Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION
1989 • 776 citations
A Gompertzian model of human breast cancer growth.
1988 • 685 citations
GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN
1988 • 585 citations
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients
1991 • 519 citations
Treatment of testicular cancer: a new and improved model.
1990 • 517 citations
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.
1988 • 384 citations
Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer.
1987 • 236 citations
Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.
1990 • 175 citations
High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.
1986 • 132 citations
Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy.
1992 • 124 citations
Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation.
1992 • 102 citations
High-dose i.v. thiotepa and cryopreserved autologous bone marrow transplantation for therapy of refractory cancer.
1987 • 76 citations
Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
1989 • 68 citations
Potential innovations in scheduling of cancer chemotherapy.
1991 • 38 citations